For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and Attruby represents a true change. These groundbreaking therapies protect the transthyretin protein, slowing its damaging build-up and alleviating the burden of t